{"database": "lobbying", "table": "lobbying_activities", "rows": [[1556109, "8f22a3f2-d6b6-448a-a55b-0e3ff44c27fe", "Q2", "AMERICAN PHARMACISTS ASSOCIATION", 3071, "AMERICAN PHARMACISTS ASSOCIATION", 2014, "second_quarter", "PHA", "HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2014-07-17T14:14:10.763000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1556109"], "units": {}, "query_ms": 13.591914961580187, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}